COVID-19 Vaccines are a Global Public Good: Op-ed by Two Emory EPI PhD Students

COVID-19 Vaccines are a Global Public Good: Op-ed by Two Emory EPI PhD Students

Category : GLEPI News/Events

Description

Even over winter break, Emory EPI students continue to devote their time and energy to finding unique ways to address the pressing public health concerns of today. First year PhD students Christina Chandra and Aniruddha Deshpande recently co-wrote an opinion piece for the AJC about COVID-19 vaccine distribution, which was published on December 31st, 2020. They argue that COVID-19 vaccines are a global public good and that our representatives can help ensure global access to vaccines, especially in low- and middle-income countries.

You can check out the full article here, be sure to read and share! 

 


Log out of this account

Leave a Reply

Upcoming Events

  • EGDRC Seminar: Lynn Aboue-Jaoudé January 14, 2025 at 12:00 pm – 1:00 pm Seminar Series; tinyurl.com… Online Location: https://tinyurl.com/Lynn-Abou-JaoudeEvent Type: Seminar SeriesSeries: Health System Users in Vulnerable Situations: Normative Experiences and “New Ways of Life”Speaker: Lynn Abou-JaoudéContact Name: Wendy GillContact Email: wggill@emory.eduLink: https://tinyurl.com/Lynn-Abou-JaoudeDr. Lynn Abou-Jaoudé studies sociocultural challenges in healthcare experiences, focusing on qualitative research and diabetes prevention at the University of Lille’s LUMEN lab.
  • GCDTR Seminar: Erin Ferranti, PhD, MPH, RN January 21, 2025 at 12:00 pm – 1:00 pm Seminar Series; tinyurl.com… Online Location: https://tinyurl.com/ErinFerrantiEvent Type: Seminar SeriesSeries: Cardiometabolic Risk and Resource Connection in Maternal HealthSpeaker: Erin Ferranti, PhD, MPH, RNContact Name: Wendy GillContact Email: wggill@emory.eduRoom Location: RRR_R809Link: https://tinyurl.com/ErinFerrantiDr. Erin Ferranti, Emory Assistant Professor, researches women’s cardiometabolic disease prevention, health inequities, maternal morbidity, farmworker health, diabetes, and hypertension using biomarkers for early risk identification.

Follow Us on Social Media: